.jpg){kind=logo}
A multi-institutional study led by Moffitt Cancer Center found that percutaneous hepatic perfusion using a melphalan hepatic delivery system may help patients with a rare eye cancer that has spread to their liver. This disease, known as metastatic uveal melanoma, is traditionally very hard to treat and usually has poor outcomes...
Make Money with Automated Trading!
Copyright © 2023 wallsteetneversleeps. All Rights Reserved
